Ono Pharmaceutical Dividend
Dividend criteria checks 6/6
Ono Pharmaceutical is a dividend paying company with a current yield of 4.09% that is well covered by earnings. Next payment date is on 2nd December, 2024 with an ex-dividend date of 27th September, 2024.
Key information
4.1%
Dividend yield
20%
Payout ratio
| Industry average yield | 2.2% |
| Next dividend pay date | 02 Dec 24 |
| Ex dividend date | 27 Sep 24 |
| Dividend per share | JP¥80.000 |
| Earnings per share | JP¥202.55 |
| Future Dividend Yield | 4.0% |
Recent dividend updates
Recent updates
We Think Ono Pharmaceutical (TSE:4528) Can Stay On Top Of Its Debt
Aug 25
Ono Pharmaceutical Co., Ltd. (TSE:4528) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 04There's No Escaping Ono Pharmaceutical Co., Ltd.'s (TSE:4528) Muted Earnings
Jun 24Ono Pharmaceutical (TSE:4528) Has Announced A Dividend Of ¥40.00
Mar 04Is There An Opportunity With Ono Pharmaceutical Co., Ltd.'s (TSE:4528) 42% Undervaluation?
Feb 27Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 4528's dividends per share have been stable in the past 10 years.
Growing Dividend: 4528's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Ono Pharmaceutical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (4528) | 4.1% |
| Market Bottom 25% (JP) | 1.8% |
| Market Top 25% (JP) | 3.8% |
| Industry Average (Pharmaceuticals) | 2.2% |
| Analyst forecast (4528) (up to 3 years) | 4.0% |
Notable Dividend: 4528's dividend (4.09%) is higher than the bottom 25% of dividend payers in the JP market (1.83%).
High Dividend: 4528's dividend (4.09%) is in the top 25% of dividend payers in the JP market (3.82%)
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (19.8%), 4528's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (40.9%), 4528's dividend payments are well covered by cash flows.